The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
Open accessAbstract
BACKGROUND: Patients' responses to oral antiplatelet therapy are subject to variation. Bedside monitoring offers the opportunity to improve outcomes after coronary stenting by individualizing therapy. METHODS: We randomly assigned 2440 patients scheduled for coronary stenting at 38 centers to a strategy of platelet-function monitoring, with drug adjustment in patients who had a poor response to antiplatelet therapy, or to a conventional strategy without monitoring and drug adjustment. The primary end point was the composite of death, myocardial infarction, stent thrombosis, stroke, or urgent revascularization 1 year after stent implantation. For patients in the monitoring group, the VerifyNow P2Y12 and aspirin point-of-care assays were used in the catheterization laboratory before stent implantation and in the outpatient clinic 2 to 4 weeks later. RESULTS: In the monitoring group, high platelet reactivity in patients taking clopidogrel (34.5% of patients) or aspirin (7.6%) led to the administration of an additional bolus of clopidogrel, prasugrel, or aspirin along with glycoprotein IIb/IIIa inhibitors during the procedure. The primary end point occurred in 34.6% of the patients in the monitoring group, as compared with 31.1% of those in the conventional-treatment group (hazard ratio, 1.13; 95% confidence interval [CI], 0.98 to 1.29; P=0.10). The main secondary end point, stent thrombosis or any urgent revascularization, occurred in 4.9% of the patients in the monitoring group and 4.6% of those in the conventional-treatment group (hazard ratio, 1.06; 95% CI, 0.74 to 1.52; P=0.77). The rate of major bleeding events did not differ significantly between groups. CONCLUSIONS: This study showed no significant improvements in clinical outcomes with platelet-function monitoring and treatment adjustment for coronary stenting, as compared with standard antiplatelet therapy without monitoring. (Funded by Allies in Cardiovascular Trials Initiatives and Organized Networks and others; ARCTIC ClinicalTrials.gov number, NCT00827411.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, large, superiority RCTs have failed to show a higher efficacy of routine platelet-function testing in guiding antiplatelet therapy post-PCI.322,322a”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [322]
In the citing paper
“Current evidence does not support platelet function testing to adjust DAPT.”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [322]
In the citing paper
“Despite initial enthusiasm, multiple large, randomized studies have failed to show any clinical benefit when antithrombotic regimens are adjusted on the basis of platelet function testing.60–62”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
Self-citationGuidelines on myocardial revascularization
Wijns, W. C., Kolh, P. H., Danchin, N., Mario, C. D., Falk, V., Folliguet, T. A., Garg, S., Huber, K., James, S. K., Knuuti, J., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,228
Price, M. J. (2011) · JAMA · doi:10.1001/jama.2011.290 · Cited by 1,311
Lincoff, A. M., Bittl, J. A., Harrington, R. A., Feit, F., Kleiman, N. S., Jackman, J. D., Sarembock, I. J., Cohen, D. J., Spriggs, D. J., Ebrahimi, R., et al. (2003) · JAMA · doi:10.1001/jama.289.7.853 · Cited by 1,158
Bonello, L., Tantry, U. S., Marcucci, R., Blindt, R., Angiolillo, D. J., Becker, R. C., Bhatt, D. L., Cattaneo, M., Collet, J., Cuisset, T., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.047 · Cited by 1,151
Self-citationPrasugrel versus clopidogrel for acute coronary syndromes without revascularization
Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1205512 · Cited by 874
Breet, N. J., van Werkum, J. W., Bouman, H. J., Kelder, J. C., Ruven, H. J. T., Bal, E. T., Deneer, V. H. M., Harmsze, A. M., der Heyden, J. A. S. V., Rensing, B. J. W. M., et al. (2010) · JAMA · doi:10.1001/jama.2010.181 · Cited by 850
Mehta, S. R., Tanguay, J., Eikelboom, J. W., Jolly, S. S., Joyner, C. D., Granger, C. B., Faxon, D. P., Rupprecht, H., Budaj, A., Avezum, Á., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61088-4 · Cited by 812
Self-citationThrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Tricoci, P., Huang, Z., Held, C., Moliterno, D. J., Armstrong, P. W., de Werf, F. V., White, H. D., Aylward, P. E., Wallentin, L. C., Chen, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109719 · Cited by 756
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 883
Progress in Platelet Blockers: The Target is the P2Y12 Receptor
Patel, P. A., Lane, B. J., & Augoustides, J. G. (2013) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2013.01.008 · Cited by 18
Direct oral anticoagulants and antiplatelet agents
Spannagl, M., & Sibbing, D. (2013) · Hämostaseologie · doi:10.5482/hamo-13-11-0055 · Cited by 17
Marcucci, R., Valente, S., Gori, A. M., Chiostri, M., Paniccia, R., Giusti, B., Cau, V., Lazzeri, C., Gensini, G. F., & Abbate, R. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.07.020 · Cited by 17
EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE
Mirzaev, K. B., Andreev, D. A., & Sychev, D. A. (2015) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2015-11-1-85-91 · Cited by 17
Adamski, P., Sikora, J., Sikora, A., Karczmarska‐Wódzka, A., Marszał, M., Boińska, J., Laskowska, E., Obońska, E., Fabiszak, T., Kubica, J., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-07-0535 · Cited by 17
Aggregometry in the settings of thrombocytopenia, thrombocytosis and antiplatelet therapy
Podda, G. M., Scavone, M., Femia, E. A., & Cattaneo, M. (2018) · Platelets · doi:10.1080/09537104.2018.1445843 · Cited by 17
Mallouk, N., Varvat, J., Berger, A., Epinat, M., Accassat, S., Garcin, A., Montmartin, A., Li, G., Garnier, P., Mismetti, P., et al. (2018) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2018.02.002 · Cited by 17
Rocca, D. G. D., Horton, R., Biase, L. D., Gianni, C., Trivedi, C. G., Mohanty, S., Anannab, A., Magnocavallo, M., Chen, Q., Tarantino, N. M., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.04.012 · Cited by 17
Geisler, T., Booth, J., Tavlaki, E., Karathanos, A., Müller, K., Droppa, M., Gawaz, M., Yanez-Lopez, M., Davidson, S. J., Stables, R. H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135037 · Cited by 17
Hartmann, J., & Curzen, N. P. (2022) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0042-1757545 · Cited by 16
Shpigelman, J., Proshkina, A., Daly, M. J., & Cox, D. M. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01892-9 · Cited by 16
Clopidogrel resistance and its relevance: Current concepts
Pradhan, A. K., Bhandari, M., Vishwakarma, P., & Sethi, R. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1473_23 · Cited by 16
Sardella, G., Calcagno, S., Mancone, M., Lucisano, L., Pennacchi, M., Stio, R. E., Placentino, F., Roma, A. D., Cavallo, E., Palmirotta, R., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.085 · Cited by 16
The future of P2Y12 receptor antagonists
Thomas, M. R., & Storey, R. F. (2015) · Platelets · doi:10.3109/09537104.2015.1049519 · Cited by 16
de Raucourt, E., Roussel‐Robert, V., & Zetterberg, E. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12498 · Cited by 16
Hibbert, B. M., Maze, R., Pourdjabbar, A., Simard, T., Ramirez, F. D., Moudgil, R., Blondeau, M., Labinaz, M. X., DICK, A. J., Glover, C. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092078 · Cited by 16
Saia, F., Marino, M., Campo, G. C., Valgimigli, M., Guastaroba, P., Taglieri, N., Tondi, S., Manari, A., Guiducci, V., Sangiorgio, P., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.05.010 · Cited by 16
P2Y12receptor inhibitors for secondary prevention of ischemic stroke
Liu, F., Tantry, U. S., & Gurbel, P. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1035256 · Cited by 17
Stratz, C., Leggewie, S., Hochholzer, W., Valina, C. M., Gick, M., Kirtane, A. J., Stone, G. W., Neumann, F., Trenk, D., & Nührenberg, T. G. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0257 · Cited by 16
Johnson, T., Mumford, A. D., Scott, L. J., Mundell, S. J., Butler, M. J., Strange, J., Rogers, C. A., Reeves, B. C., & Baumbach, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144984 · Cited by 16
Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry
Brodie, B. R., Garg, A., Stuckey, T., Kirtane, A. J., Witzenbichler, B., Maehara, A., Weisz, G., Rinaldi, M. J., Neumann, F., Metzger, D. C., et al. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.002568 · Cited by 16
Kim, J., Heo, S., Choi, K., Nam, T., Choi, S., Lee, S., Park, M., Kim, B. C., Kim, M., Saver, J. L., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.009428 · Cited by 16
Gupta, R., Kirtane, A. J., Ozan, M. O., Witzenbichler, B., Rinaldi, M. J., Metzger, D. C., Weisz, G., Stuckey, T., Brodie, B. R., Mehran, R., et al. (2017) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004904 · Cited by 16
The Current Role of Platelet Function Testing in Clinical Practice
Mason, G., & Rabbolini, D. J. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1728786 · Cited by 16
Clinical Impact of Pharmacogenomics of Clopidogrel in Stroke
Simon, T., & Danchin, N. (2016) · Circulation · doi:10.1161/circulationaha.116.025198 · Cited by 16
Role of platelet function testing in acute coronary syndromes: a meta-analysis
Aluvilu, A., & Ferro, A. (2022) · Open Heart · doi:10.1136/openhrt-2022-002129 · Cited by 15
Masi, P., Gendreau, S., Moyon, Q., Leguyader, M., Lebreton, G., Ropers, J., Dangers, L., Sitruk, S., Bréchot, N., de Chambrun, M. P., et al. (2024) · Journal of Critical Care · doi:10.1016/j.jcrc.2024.154771 · Cited by 15
Desai, N. R., Canestaro, W. J., Kyrychenko, P., Chaplin, D., Martell, L. A., Brennan, T. A., Matlin, O. S., & Choudhry, N. K. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000321 · Cited by 15
Rossington, J. A., Brown, O. I., & Hoye, A. (2016) · Open Heart · doi:10.1136/openhrt-2015-000296 · Cited by 16
Bagai, A., Peterson, E. D., McCoy, L. A., Effron, M. B., Zettler, M. E., Stone, G. W., Henry, T. D., Cohen, D. J., Schulte, P. J., Anstrom, K. J., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.02.003 · Cited by 15
Olechowski, B., Dalton, R., Khanna, V., Ashby, A., Vavyla, M., Mariathas, M., Harris, S., Nicholas, Z., Mahmoudi, M., & Curzen, N. P. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12433 · Cited by 15
Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation
Giustino, G., Redfors, B., Kirtane, A. J., Mehran, R., Dangas, G., Witzenbichler, B., Neumann, F., Weisz, G., Généreux, P., Maehara, A., et al. (2018) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2018.01.263 · Cited by 15
Wu, H., Zhang, C., Zhao, X., Qian, J., Wang, Q., & Ge, J. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0278-9 · Cited by 15
Guedeney, P., & Collet, J. (2021) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1722188 · Cited by 15
Self-citationLi, J., Yuan, D., Jiang, L., Tang, X., Xu, J., Song, Y., Chen, J., Qiao, S., Yang, Y., Gao, R., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.736466 · Cited by 15
Cluster-Randomized Clinical Trial Examining the Impact of Platelet Function Testing on Practice
Wang, T. Y., Henry, T. D., Effron, M. B., Honeycutt, E. F., Hess, C. N., Zettler, M. E., Cohen, D. J., Baker, B., Berger, P. B., Anstrom, K. J., et al. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001712 · Cited by 15
Does the VerifyNow P2Y12 assay overestimate “therapeutic response” to clopidogrel?
Khanna, V., Hobson, A. R., Mikael, R., Sambu, N., Englyst, N. A., & Curzen, N. P. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-10-0856 · Cited by 15
Saleh, A., Hammoudeh, A. J., Tabbalat, R. A., Al-haddad, I., Al-Mousa, E. N., Jarrah, M., Izraiq, M., Nammas, A., Janabi, H., Hazaymeh, L., et al. (2016) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2016.17 · Cited by 15
Podda, G. M., Grossi, E., Palmerini, T., Buscema, M., Femia, E. A., Riva, D. D., Servi, S. D., Calabrò, P., Piscione, F., Maffeo, D., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.074 · Cited by 15
Amin, A. M., Chin, L. S., Teh, C.-H., Mostafa, H. M. A., Noor, D. A. M., Kader, M. A. S. A., Hay, Y. K., & Ibrahim, B. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.08.018 · Cited by 15
Verdoia, M., Pergolini, P., Nardin, M., Rolla, R., Barbieri, L., Marino, P. N., Carriero, A., Suryapranata, H., & Luca, G. D. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.10.005 · Cited by 15
Bedside Monitoring of Antiplatelet Therapy for Coronary Stenting
Montalescot, G., Vicaut, É., & Collet, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1300053 · Cited by 15
Self-citationPennings, G. J., Reddel, C. J., Chen, V. M. Y., Gnanenthiran, S. R., & Kritharides, L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1104744 · Cited by 14
Extracellular Vesicles in Coronary Artery Disease
Buntsma, N. C., van der Pol, E., Nieuwland, R., & Gąsecka, A. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_6 · Cited by 14
Neurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do?
Kass‐Hout, T., Alderazi, Y. J., Amuluru, K., Jin, P., Ayala, C., Prestigiacomo, C. J., & Gandhi, C. D. (2014) · Interventional Neurology · doi:10.1159/000431261 · Cited by 14
Tailored antiplatelet therapy and clinical adverse outcomes
Li, J., Zhao, J., Song, M., Guo, W., Chen, G., Lü, W., Qian, D., Ouyang, J., Yu, J., Hu, H., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304461 · Cited by 14
Ozawa, T., Suda, M., Ikegami, R., Takano, T., Wakasugi, T., Yanagawa, T., Tanaka, K., Ozaki, K., Hirono, S., & Minamino, T. (2017) · International Heart Journal · doi:10.1536/ihj.17-005 · Cited by 14
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention
Choi, K. H., Park, Y. H., Song, Y. B., Park, T. K., Lee, J. M., Yang, J. H., Choi, J., Choi, S., Oh, J. H., Chun, W. J., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.3203 · Cited by 14
Guimarães, P. O., & Tricoci, P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1074180 · Cited by 14
Urban, P. M., Valdés, M., Menown, I. B. A., Eberli, F. R., Alhaddad, I. A., Hildick‐Smith, D., Iosseliani, D. G., Roffi, M., Oldroyd, K. G., Kalloudi, E., et al. (2015) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25892 · Cited by 14
High platelet reactivity on aspirin in patients with acute ST elevation myocardial infarction
Dillinger, J., Saeed, A., Spagnoli, V., Sollier, C. B. D., Sidéris, G., Manzo‐Silberman, S., Voicu, S., Drouet, L. O., & Henry, P. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.05.002 · Cited by 14
Self-citationYi, X., Lin, J., Wang, C., Huang, R., Han, Z., & Li, J. (2017) · Oncotarget · doi:10.18632/oncotarget.22293 · Cited by 14
Mangiacapra, F., Colaiori, I., Ricottini, E., Creta, A., Gioia, G. D., Cavallari, I., Bressi, E., Capuano, M., Barbato, E., & Sciascio, G. D. (2018) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-018-1630-5 · Cited by 14
Zhao, S., Zhong, Z., Qi, G., Shi, L., & Tian, W. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0711-8 · Cited by 14
Chen, Y.-C., Lin, F., Lin, Y., Cheng, S., Lin, R.-H., Chuang, C., Sheu, J.-S., Chen, S.-M., Chang, C.-C., & Tsai, C. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0302-3 · Cited by 14
Ferguson, L., Duong, P., Pearce, K. F., Murphy, P., & Biss, T. T. (2018) · ASAIO Journal · doi:10.1097/mat.0000000000000768 · Cited by 14
Viswanathan, G. N., Marshall, S. M., Balasubramaniam, K., Badimón, J. J., & Zaman, A. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.01.033 · Cited by 14
for the DOSAPI investigators., Collet, J., Hulot, J., Abtan, J., Anzaha, G., Kernéis, M., Silvain, J., Cayla, G., O’Connor, S. A., Barthélémy, O., et al. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1710-1 · Cited by 13
Self-citationAhn, S. G., Yoon, J., Kim, J.-W., Uh, Y., Kim, K. M., Lee, J. H., Lee, J., Youn, Y. J., Ahn, M., Kim, J., et al. (2013) · Korean Circulation Journal · doi:10.4070/kcj.2013.43.8.541 · Cited by 13
Bernlochner, I., Mayer, K., Morath, T., Orban, M., Schulz, S., Schömig, A., Braun, S., Kastrati, A., & Sibbing, D. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0552 · Cited by 13
Spinthakis, N., Farag, M., Rocca, B., & Gorog, D. A. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007754 · Cited by 13
Clinical Significance of Acute and Serial Platelet Function Testing in Acute Ischemic Stroke
Kim, J., Choi, K., Park, M., Lee, J. S., Saver, J. L., & Cho, K. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008313 · Cited by 13
Blunting periprocedural myocardial necrosis: Rationale and design of the randomized ALPHEUS study
Silvain, J., Cayla, G., Beygui, F., Rangé, G., Lattuca, B., Collet, J., Dillinger, J., Boueri, Z., Brunel, P., Pouillot, C., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.04.017 · Cited by 13
Self-citationAcute coronary syndrome and renal impairment: a systematic review
Mauro, M. D., Fiorentini, V., Mistrulli, R., Veneziano, F. A., & Luca, L. D. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2302049 · Cited by 13
Monitoring antiplatelet therapy: where are we now?
Marcucci, R., Berteotti, M., Gragnano, F., Galli, M., Cavallari, I., Renda, G., Capranzano, P., Santilli, F., Capodanno, D., Angiolillo, D. J., et al. (2022) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001406 · Cited by 13
Qiu, L., Wang, L., Li, X., Han, R., Xia, X., & Liu, J. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.01.004 · Cited by 13
Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome
Collet, J., Kernéis, M., Hulot, J., O’Connor, S. A., Silvain, J., Mansencal, N., Brugier, D., Abtan, J., Barthélémy, O., Vignalou, J.-B., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-05-0394 · Cited by 13
Self-citationGonzález, A., Ortega-Quintanilla, J., Zapata‐Arriaza, E., de Albóniga-Chindurza, A., Garcia-Lozano, J. R., Vega, M. I. L., & Cayuela, A. (2019) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2019-015288 · Cited by 13
Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr
Lindholm, D. P., Storey, R. F., Christersson, C., Halvorsen, S., Grove, E. L., Braun, O. Ö., Varenhorst, C., & James, S. K. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.06.014 · Cited by 13
Park, J., Shin, D., Kim, B., Her, A., Kim, Y. H., Choi, H. H., Kim, J., Ko, Y., Choi, D., Jang, Y., et al. (2013) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jet088 · Cited by 12
CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome
Asher, E., Abu‐Much, A., Bragazzi, N. L., Younis, A., Younis, A., Massalha, E., Goldkorn, R., Mazin, I., Fefer, P., Barbash, I. M., et al. (2020) · Journal of Cardiology · doi:10.1016/j.jjcc.2020.09.010 · Cited by 12
Golukhova, E. Z., Grigorian, M. V., Николаевна, Р. М., Bulaeva, N. I., Fortmann, S. D., & Serebruany, V. L. (2015) · Cardiology · doi:10.1159/000435909 · Cited by 12
Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization
Joseph, P. G., Paré, G., Ross, S. A., Roberts, R., & Anand, S. S. (2013) · Clinical Cardiology · doi:10.1002/clc.22200 · Cited by 12
Friedman, E. A., Texeira, L., Delaney, J. T., Weeke, P. E., Lynch, D., Kasasbeh, E. S., Song, Y., Harrell, F. E., Denny, J. C., Hamm, H. E., et al. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1285-4 · Cited by 12
Ma, W., Liang, Y., Zhu, J. W., Wang, Y., & Wang, X. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.12.013 · Cited by 12
Abtan, J., Silvain, J., Kernéis, M., O’Connor, S. A., Barthélémy, O., Vignalou, J.-B., Beygui, F., Brugier, D., Collet, J., & Montalescot, G. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-03-0203 · Cited by 12
Self-citationLiu, X., Luo, Y., Lai, Y., Yao, Y., Li, J., Wang, Y., ZHENG, S. L., Xu, J., & Liu, X. (2016) · Journal of Genetics · doi:10.1007/s12041-016-0618-1 · Cited by 12
Platelet Function Testing As a Biomarker for Efficacy of Antiplatelet Drugs
Lordkipanidzé, M., So, D. Y. F., & Tanguay, J. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0070 · Cited by 12
Komócsi, A., Aradi, D., Szük, T., Nagy, G. G., Noori, E., Ruzsa, Z., Kiss, R. G., Andrássy, P., Nagy, L., Nagy, F. T., et al. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.032 · Cited by 12
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
Lomakin, N. V., Rudakova, A., Buryachkovskaya, L. I., & Serebruany, V. L. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.29.2 · Cited by 12
Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion
Gregorio, M. G. D., Marcucci, R., Migliorini, A., Gori, A. M., Giusti, B., Vergara, R., Paniccia, R., Carrabba, N., Marchionni, N., & Valenti, R. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014676 · Cited by 12
Good, R., McGarrity, A. M., Sheehan, R., James, T. E., Miller, H., Stephens, J. C., Watkins, S., McConnachie, A., Goodall, A. H., & Oldroyd, K. G. (2014) · Platelets · doi:10.3109/09537104.2013.870334 · Cited by 12
Khanna, V., Armstrong, P. C. J., Warner, T. D., & Curzen, N. P. (2015) · Platelets · doi:10.3109/09537104.2014.1001832 · Cited by 12
Zhu, H.-C., Li, Y., Guan, S.-Y., Li, J., Wang, X., Jing, Q., Wang, Z., & Han, Y. (2015) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2015.01.003 · Cited by 12
Cecchi, E., Marcucci, R., Chiostri, M., Mecarocci, V., Spini, V., Innocenti, L., Calabretta, R., Cordisco, A., Romano, S. M., Abbate, R., et al. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1242-4 · Cited by 12
Report of the American Heart Association (AHA) Scientific Sessions 2012, Los Angeles
Fujita, J. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-1490 · Cited by 11
Clopidogrel Dose Adjustment After Outpatient Screening for CYP2C19 Variant Alleles: A Pilot Study
Rossi, J. S., Cammarata, M., Dharmavaram, J., Weck, K. E., Walko, C. M., Gabriel, D. A., Kuritzky, J. J., Muldrew, K. L., & Stouffer, G. A. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.17 · Cited by 11
Chen, H., Power, D., & Giustino, G. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1523718 · Cited by 11
Endothelial Shear Stress and Platelet FcγRIIa Expression in Intracranial Atherosclerotic Disease
Liebeskind, D. S., Hinman, J. D., Kaneko, N., Kitajima, H., Honda, T., de Havenon, A., Feldmann, E. G., Nogueira, R. G., Prabhakaran, S., Romano, J. G., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.646309 · Cited by 11
Genotype-Guided Use of P2Y12 Inhibitors: A Review of Current State of the Art
Al-Abcha, A. K., Radwan, Y., Blais, D. M., Mazzaferri, E. L., Boudoulas, K. D., Essa, E. M., & Gumina, R. J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.850028 · Cited by 11
Birocchi, S., Rocchetti, M., Minardi, A., Podda, G. M., Squizzato, A., & Cattaneo, M. (2023) · Thrombosis and Haemostasis · doi:10.1055/a-2149-4344 · Cited by 11
Rantamo, A., Gallé, C., Numminen, J., Virta, J. J., Tanskanen, P., Lindroos, A.-C., Resendiz‐Nieves, J., Lehečka, M., Niemela, M. R., Haeren, R. H. L., et al. (2024) · Acta Neurochirurgica · doi:10.1007/s00701-024-06029-7 · Cited by 11
Treatment Options for Patients With Poor Clopidogrel Response
Roberts, D. I., & Nawarskas, J. J. (2013) · Cardiology in Review · doi:10.1097/crd.0b013e3182a72fab · Cited by 11
Antiplatelet Strategies for Secondary Prevention of Stroke and TIA
Ishida, K., & Messe, S. R. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0449-6 · Cited by 11
Medical therapy of coronary artery disease after percutaneous intervention
Kurz, D. J., & Eberli, F. R. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.01.011 · Cited by 11
Antiplatelet testing in neurointervention: we cannot ignore the signs
Leslie‐Mazwi, T. M. (2013) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2013-010809 · Cited by 11
Li, S., Liu, H., & Liu, J. (2016) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1366-z · Cited by 11
Bleeding events and maintenance dose of prasugrel: BLESS pilot study
Carrabba, N., Parodi, G., Marcucci, R., Valenti, R., Gori, A. M., Migliorini, A., Comito, V., Bellandi, B., Abbate, R., Gensini, G. F., et al. (2016) · Open Heart · doi:10.1136/openhrt-2016-000460 · Cited by 11
Kheiri, B., Osman, M., Abdalla, A., Chahine, A., Ahmed, S. A., Osman, K., Bachuwa, G. I., Hassan, M., & Bhatt, D. L. (2018) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248418809098 · Cited by 11
Kheiri, B., Abdalla, A., Osman, M., Barbarawi, M., Zayed, Y., Haykal, T., Chahine, A., Bachuwa, G. I., Hassan, M., & Bhatt, D. L. (2019) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.28075 · Cited by 11
Metadata
- Authors
- Collet, J.-P., Cuisset, T., Rangé, G., Cayla, G., Elhadad, S., Pouillot, C., Henry, P., Motreff, P., Carrié, D., Boueri, Z., Belle, L., Van Belle, E., Rousseau, H., Aubry, P., Monségu, J., Sabouret, P., O'Connor, S. A., Abtan, J., Kerneis, M., Saint-Etienne, C., Barthélémy, O., Beygui, F., Silvain, J., Vicaut, E., & Montalescot, G.
- Affiliations
- Pitié-Salpêtrière Hospital (FR)
- Hôpital de la Timone (FR)
- Les Hôpitaux de Chartres (FR)
- Centre Hospitalier Universitaire de Nîmes (FR)
- Hôpital Lariboisière (FR)
- Centre Hospitalier Universitaire de Clermont-Ferrand (FR)
- Hôpital Rangueil (FR)
- Hôpital Bichat-Claude-Bernard (FR)
- HIA du Val-de-Grâce à Paris (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-11-29
- Volume
- 367
- Issue
- 22
- Pages
- 2100-2109
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2145323902
- Cited by
- 887
- References
- 26
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 22 · 2023: 31 · 2022: 31 · 2021: 47 · 2020: 44 · 2019: 52 · 2018: 72 · 2017: 77 · 2016: 80 · 2015: 123 · 2014: 122 · 2013: 141 · 2012: 8
- FWCI
- 81.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- antiplatelet therapy, coronary stenting, platelet function monitoring, VerifyNow P2Y12 assay, clopidogrel, prasugrel, aspirin, stent thrombosis, bleeding events, glycoprotein IIb/IIIa inhibitors, individualized dosing, major adverse cardiovascular events
- MeSH terms
- Prasugrel Hydrochloride, Clopidogrel, Aged, Aspirin, Coronary Disease, Coronary Thrombosis, Female, Humans, Male, Middle Aged, Myocardial Infarction, Piperazines, Platelet Aggregation Inhibitors, Pyridines, Thiophenes, Ticlopidine, Stents, Drug Monitoring, Point-of-Care Systems, Retreatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
